Cointime

FoRx Therapeutics

company

About

FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.

  • 1 - 10

Highlights

Total Funding Amount
€10M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Seed
Last Funding Money Raised
€10M
Industries
Biotechnology,Life Science
Founded date
Oct 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

FoRx Therapeutics is a recently incorporated privately-held company aiming to develop first-in-class compounds for cancer treatment.
FoRx focuses on drugging key molecular targets involved in DNA replication stress, as a new approach towards the development of targeted anticancer drugs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€10M
FoRx Therapeutics has raised a total of €10M in funding over 2 rounds. Their latest funding was raised on Apr 22, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 22, 2020 Seed €10M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
FoRx Therapeutics is funded by 1 investors. Pfizer are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer — Seed
Cointime
เนื้อหา
บริษัท